The European Commission has pledged €360 million to Gavi, the Vaccine Alliance at the “Health and Prosperity through Immunisation” global summit in Brussels on Wednesday 25 June. The total financial commitment of the European Union, its Member States and its private partners through ‘Team Europe’ amounts to more than €2 billion, out of $9 billion guaranteed and a target of $11.9 billion for the period 2026-2030.
This financial support is intended to enable Gavi to continue its work promoting immunisation in low- and middle-income countries, with the aim of protecting 500 million children against preventable diseases, preventing up to 9 million deaths and strengthening global health security by building up strategic stocks of vaccines against diseases such as cholera, monkeypox and Ebola.
“For over 20 years, we have stood side by side [Gavi], with the European Union contributing over €3.2 billion to vaccinate more than 1 billion children against deadly diseases. But millions still need this vital protection”, said Commission President Ursula von der Leyen on Wednesday.
In addition to the European Commission’s commitment, on Wednesday the European Investment Bank (EIB) announced the extension of its €1 billion liquidity facility, allowing donors to meet their pledges flexibly.
To support local vaccine production in Africa, €800 million was announced by Team Europe last June (see EUROPE 13436/32), while the Commission announced €260 million for the period 2026-2027 last September (see EUROPE 13493/6). (Original version in French by Bernard Denuit)